List of Studies ( Metabolite:PA 34:2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Blood | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Bone marrow serum | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003785 | AN006219 | Sex differences in lipid profiles of visceral adipose tissue with obesity and gonadectomy | Tissue | Mouse | Obesity | University of Michigan | LC-MS |
| ST003776 | AN006202 | Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion | Liver | Mouse | Environmental exposure | University of Bonn | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003521 | AN005783 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | LC-MS |
| ST003407 | AN005591 | Deficiency in glutathione peroxidase 4 (GPX4) results in abnormal lens development and newborn cataract | Eye tissue | Mouse | Eye disease | Augusta University | LC-MS |
| ST003144 | AN005160 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003114 | AN005102 | Lipidomics analyses in model membranes, isolated mitochondria and cellular systems to study how the local lipid environment affects BAX and BAK function during apoptosis. | Mitochondria | Human | Cancer | University of Cologne | LC-MS |
| ST003090 | AN005055 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST003051 | AN005003 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | University of Kansas | LC-MS | |
| ST002792 | AN004543 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002782 | AN004529 | Lipidomics analysis of maternal obesity model - knock out | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002732 | AN004429 | Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus | Blood | Human | Systemic lupus erythematosus | INSERM | LC-MS |
| ST002400 | AN003907 | Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis | Cultured cells | Human | INSERM | LC-MS | |
| ST002360 | AN003854 | Quantitative lipidomics of TFG-deficient B cells | Cultured cells | Mouse | University of Cologne | MS(Dir. Inf.) | |
| ST002335 | AN003814 | Pathogenic Auxilin mutations affect lipids that are critical to Synaptojanin function | Insect tissue | Fruit fly | Parkinsons disease | VIB-KU Leuven | MS(Dir. Inf.) |
| ST002309 | AN003772 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002252 | AN003679 | Lipidomics analysis on Arabidopsis autophagy mutants | Plant | Arabidopsis thaliana | Iowa State University | MS(Dir. Inf.) | |
| ST002140 | AN003502 | Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling flux of the TCA cycle | B-cells | Mouse | University of Erlangen-Nürnberg | LC-MS/MS(Dir. Inf.) | |
| ST002135 | AN003495 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples. (Part 2) | Blood | Human | University of Michigan | LC-MS | |
| ST002134 | AN003491 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples (Part 1) | Blood | Human | University of Michigan | LC-MS | |
| ST002057 | AN003349 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Cultured cells | Human | NASH | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001859 | AN003013 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001859 | AN003014 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001831 | AN002973 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort (part II) | Blood | Human | University of Michigan | LC-MS | |
| ST001819 | AN002951 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001315 | AN002190 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001304 | AN002173 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | LC-MS |
| ST001292 | AN002150 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001951 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001111 | AN001806 | Breast Cancer Lipidomics Tissue | Adipose tissue | Human | Cancer | Baylor College of Medicine | LC-MS |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000915 | AN001490 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000842 | AN001358 | Muscle and plasma before and after exercise | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000841 | AN001351 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | Muscle | Human | Obesity | University of Michigan | LC-MS |
| ST000823 | AN001308 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Cyst fluid | Human | Cancer | University of Michigan | LC-MS |
| ST000818 | AN001298 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | Blood | Human | Heart disease | University of Michigan | LC-MS |
| ST000781 | AN001236 | Rabbit Plasma Lipidomics with high fat diet and treatment | Blood | Rabbit | University of Michigan | LC-MS | |
| ST000780 | AN001234 | High fat diet and sciatic nerves functions | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000763 | AN001203 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Blood | Human | Scleroderma | University of Michigan | LC-MS |
| ST000759 | AN001196 | Age and exercise effect on metabolomics in rats | Unspecified | Rat | University of Michigan | LC-MS | |
| ST000744 | AN001165 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Unspecified | Human | Diabetes | University of Michigan | LC-MS |
| ST000743 | AN001161 | Metabolomics of bariatric weight loss | Unspecified | Human | Diabetes | University of Michigan | LC-MS |
| ST000688 | AN001061 | Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) | Unspecified | Human | Multiple sclerosis | University of Michigan | LC-MS |
| ST000686 | AN001058 | Lipodomics and Gestational bisphenol A (BPA) exposure | Unspecified | Sheep | University of Michigan | LC-MS | |
| ST000685 | AN001056 | Lipidomics analysis for human liver cell lines | Cultured cells | Human | University of Michigan | LC-MS | |
| ST000683 | AN001052 | Untargeted Lipidomics for hepatic lipid profile wild type versus knockout | Liver | Mouse | University of Michigan | LC-MS | |
| ST000680 | AN001046 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part III | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000677 | AN001040 | Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations | Blood | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000676 | AN001038 | Effect of high fat diet and streptozotocin treatment on neuropathy | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000675 | AN001036 | Effects of rosiglitazone treatment on lipid composition | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000672 | AN001030 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) | Blood | Mouse | Diabetes | University of Michigan | LC-MS |
| ST000662 | AN001010 | Lipidomics of hormone-sensitive lipase variants | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Rat | Obesity | University of Michigan | LC-MS |
| ST000546 | AN000833 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000523 | AN000801 | Prenatal exposures and Metabolite and Lipid Profiles | Blood | Human | Environmental exposure | University of Michigan | LC-MS |
| ST000414 | AN000656 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000114 | AN000193 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000110 | AN000184 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | B-cells | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000076 | AN000121 | A549 Cell Study | Lung | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST000004 | AN000005 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |
